Insulin receptor substrate 2
The IRS2 gene encodes a protein that is an important component of signal transduction. It constitutes the link between various receptor tyrosine kinases and downstream effectors. For instance, it acts downstream of insulin receptor, IGF receptor, and diverse cytokin receptors. Mutations in this gene are associated with insulin resistance and type 2 diabetes mellitus.
Genetests:
Related Diseases:
References:
1. |
Taniguchi CM et al. (2005) Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.
|
2. |
Withers DJ et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice.
|
3. |
Sun XJ et al. (1995) Role of IRS-2 in insulin and cytokine signalling.
|
4. |
None (2008) A victory for PETA.
|
5. |
Selman C et al. (2008) Comment on "Brain IRS2 signaling coordinates life span and nutrient homeostasis".
|
6. |
Taguchi A et al. (2007) Brain IRS2 signaling coordinates life span and nutrient homeostasis.
|
7. |
Lin X et al. (2004) Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes.
|
8. |
Hennige AM et al. (2003) Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes.
|
9. |
Lautier C et al. (2003) Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation.
|
10. |
D'Alfonso R et al. (2003) Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes.
|
11. |
Fritsche A et al. (2001) The prevalent Gly1057Asp polymorphism in the insulin receptor substrate-2 gene is not associated with impaired insulin secretion.
|
12. |
Wang H et al. (2001) New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes.
|
13. |
Kubota N et al. (2000) Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.
|
14. |
Burks DJ et al. (2000) IRS-2 pathways integrate female reproduction and energy homeostasis.
|
15. |
Almind K et al. (1999) Search for variants of the gene-promoter and the potential phosphotyrosine encoding sequence of the insulin receptor substrate-2 gene: evaluation of their relation with alterations in insulin secretion and insulin sensitivity.
|
16. |
Withers DJ et al. (1999) Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling.
|
17. |
Mammarella S et al. (2000) Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes.
|
18. |
Uchida T et al. (2005) Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice.
|
19. |
Tobe K et al. (2001) Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver.
|
20. |
Shimomura I et al. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.
|
21. |
Terauchi Y et al. (2007) Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.
|
22. |
Ogihara T et al. (1997) 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain.
|
23. |
Böhni R et al. (1999) Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4.
|
24. |
OMIM.ORG article
Omim 600797
|
25. |
NCBI article
NCBI 8660
|
26. |
Wikipedia article
Wikipedia EN (IRS2)
|
Update: Aug. 14, 2020